Company Search:
Advanced Search
Sponsored Links
Mylan NV Company Snapshot
Mylan NV operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Mylan NV with three other companies in this sector in the United States: Daiichi Sankyo Company Limited (2018 sales of $8.68 billion of which 92% was Prescription drugs), Celgene Corporation ($15.28 billion of which 100% was Biopharmaceuticals), and CSL Limited ($7.92 billion of which 84% was CSL Behring).

Sales Analysis. Mylan NV reported sales of $11.43 billion for the year ending December of 2018. This represents a decrease of 4.0% versus 2017, when the company's sales were $11.91 billion. Contributing to the drop in overall sales was the 16.8% decline in North America, from $5.06 billion to $4.21 billion. . However, these declines were partially offset by the increase in sales of Europe (up 4.7% to $4.18 billion) and Rest of World (up 6.5% to $3.04 billion) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Mylan NV
  Stock Performance Chart for Mylan NV
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 17.61
(Figures in U.S. Dollars)
1 Week -10.5%   13 Weeks -6.8%  
4 Weeks -9.6%   52 Weeks -52.3%  
Mylan NV Key Data:
  Ticker: MYL Country: United Kingdom
  Exchanges: NAS FRA Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 11,433,900,000
(Year Ending Jan 2019).
Employees: 35,000
  Currency: U.S. Dollars Market Cap: 9,089,250,529
  Fiscal Yr Ends: December Shares Outstanding: 516,141,427
  Share Type: Common Closely Held Shares: 5,328,664
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.